SEBI Registration No - INA000003197 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS.



Top 18 stocks in focus today: Bharat Financial, Dish TV, RCom, Shilpa Medicare

Aurobindo Pharma gets USFDA nod for Ranolazine Extended Release Oral Tablet.

RBI allows foreign institutions to further buy shares of Bharat Financial.

Shilpa Medicare received 10 observations from USFDA for its Telangana plant.

Indo National to provide corporate guarantee of Rs8.5cr on behalf of subsidiary.

Punjab Chemicals to consider raising funds at its board meeting on Dec 8.

Atlas Cycles says lenders Bank of Baroda and Central Bank of India have downgraded the company’s debt to non-performing.

Hatsun Agro paid Rs2.07cr to the income tax authorities, as per the settlement commission order.

Reliance Communications says petition filed by Fortuna PR is misconceived.

IRB Infra acquired additional 2.40 lakh units of IRB invit.

Byke Hospitality acquires 3 hotels in Shimla, Kovalam and Matheran.

Dalmia Bharat, Piramal Bain tie up for Binani Cement bid, as per media reports.

Lanco Infra to sell four renewable energy assets, as per media reports.

Samyaktva Constructions bought 3.68 lakh shares or 0.7% equity at Rs215.37 each of Sical Logistics.

Trupti Karani sold 2.22 lakh shares or 0.9% equity at Rs81.74 each of C&C Constructions.

Cygnet Industries bought 17.85 lakh shares or 1.6% equity at Rs1,295.50 each of Century Textiles.

Lux Industries reported a 22% yoy decline in net profit at Rs13cr for the quarter ended September 30 compared with Rs17cr profit during the same quarter last year.

The Idea-Vodafone merger is likely to close faster, as early as next March-April, six months before the more conservative September 2018 timeline recently suggested by Vodafone Group CEO Vittorio Colao, as per media reports.

Sugar stocks in focus today, as India’s sugar production has gone up by 42% in the first two months of the current 2017-18 marketing year that started October, industry body Isma said.

Sanofi said it will continue to seek Phase 3 clinical trial waiver in India for its dengue vaccine, even as countries like the Philippines have initiated investigation on possible adverse effects of the vaccine on people.

Atul Auto net profit rose 23.5% to Rs17cr in the quarter ended September 2017 as against Rs14cr during the previous quarter ended September 2016.

Net loss of Dish TV India reported at Rs18cr in the quarter ended September 2017 as against net profit of Rs 69cr during the previous quarter ended September 2016.